(1) The Self-Care Landscape: Products, Access & Regulation

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/44

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 1:57 AM on 8/20/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

45 Terms

1
New cards

What is Self-Care?

  • SELF-CARE ≠ OTC MEDICATION

  • Self-care includes:

    • Prevention + monitoring + non-drug care + devices + medications + professional guidance

  • Self-Care Continuum - Self-care ranges from patients managing their own health to situations requiring increasing professional/medical involvement.


2
New cards

What Influences Self-Care?

A patient's self-care decisions can be influenced by many people and information sources—not just health professionals.

3
New cards

Why Self-Care Matters

  • Access

  • Convenience

  • Cost

  • Consumer autonomy

  • Health care capacity


$1 spent on nonprescription medicines → $7.33 in health-system savings.

4
New cards

Availability ≠

A product being available does NOT mean the patient has meaningful access to appropriate self-care.

5
New cards

What can prevent appropriate self-care?

Social/individual barriers

6
New cards

Easy access to a product ≠

easy access to good information

7
New cards

Availability ≠ Access

Pharmacist role:

Assess → decide if self-care is appropriate → recommend → monitor → refer when needed.

8
New cards

Nonprescription drug

medication that may be used without medical supervision

9
New cards

GRASE

Generally Recognized As Safe and Effective

10
New cards

For nonprescription use, the consumer must be able to:

Self-treat

→ Product is safe/effective when used as labeled.

Self-manage

→ Professional supervision is not required for safe/effective use.

Also:

  • Low abuse/misuse potential.

  • Benefits outweigh risks.

  • Adequate directions for use can be written.


11
New cards

If a product/device is too complicated to explain adequately →

generally not appropriate for nonprescription status.

12
New cards

Nonprescription Use

State vs Federal

States may be stricter than federal requirements for OTC access.

13
New cards

When did nonprescription drug regulation became more developed?

over time—moving toward standards for safety, efficacy, quality, drug classification, and updated OTC regulation.

14
New cards

NDA vs OTC Monograph

NDA = approval of a specific product.

OTC monograph = rulebook/recipe book describing standards for qualifying OTC products.

15
New cards

When can a prescription drug can move to OTC status?

 when it can be used safely and effectively without required prescription supervision.

16
New cards

Full vs Partial Switch

Full switch

→ all relevant doses/indications become OTC.

Partial switch

→ only certain doses/indications/durations become OTC.

Examples:

  • Omeprazole → OTC has limits; Rx may allow longer/higher use.

  • NSAIDs → some doses/uses OTC; others Rx.


17
New cards

Drug Facts label should be:

Likely to be read + likely to be understood

18
New cards

OTC recommendation should follow:

OTC label → correct use + dose + duration

19
New cards

EXAM ALERT: Professor said you will probably be asked to interpret a Drug Facts label.


20
New cards

DO NOT MEMORIZE THE EXACT LIST OF SECTIONS

Professor explicitly said she would not ask you to memorize which specific pieces are required.

🔴 KNOW HOW TO FIND/USE:

Active ingredient

→ generic drug.

Purpose

→ type/class of drug.

Uses

→ indications.

Warnings

→ patients/circumstances requiring caution.

Directions

→ OTC dosing.

Inactive ingredients

→ check for dyes/allergies/sensitivities.

21
New cards

Expiration Dates

  • OTC products generally require an expiration date.

  • After a product expires, the main concern is that it may not work as well or uncertain efficacy, rather than suddenly becoming harmful.

  • Some products may be exempt from an expiration date requirement if they meet certain stability/dosage criteria.


22
New cards

Month/year expiration →

  • product is good through the END of that month

  • Example:

    • 5/18 → good through end of May → expired beginning June 1


23
New cards

Tamper-Resistant vs Tamper-Evident

Tamper-resistant → makes access harder.

Tamper-evident → makes tampering noticeable.

24
New cards

Packaging

OTC products commonly have regulated packaging that helps protect consumers and identify possible tampering.

25
New cards

If tamper-evident packaging is missing/disrupted →

product should be returned.

26
New cards

Child-resistant packaging requirements also exist for…

nonprescription products

27
New cards

Adulterated vs Misbranded

Adulterated

Problem with the product itself → may make it harmful

Examples:

  • Filthy/putrid/decomposed substance.

  • Harmful container.

  • Unsanitary manufacturing/storage.

Misbranded

Problem with labeling/presentation

Examples:

  • False/misleading labeling.

  • Required information missing.

  • Deceptive container.


28
New cards

Recalls - types?

Class I = most severe health problems/death

Class II = temporary/slighter risk

Class III = unlikely harm but regulatory problem

29
New cards

Recalls - Seller/pharmacist:

  • Know recalled products.

  • Stop selling/dispensing.

  • Contact customers when necessary.

  • The more serious the recall, the more likely the pharmacy may need to actively contact previous purchasers.


30
New cards

Brand name ≠

active ingredient

31
New cards

A brand family may contain different:

  • Strengths

  • Formulations/Ingredient combinations

  • Therapeutic products


32
New cards

Same/similar brand name →

  • wrong product selected

  • solution - Pay attention to active ingredients.


33
New cards

 Nonprescription Advertising

Nonprescription drug advertising is regulated and claims should be truthful/forthright.

34
New cards
35
New cards

Restricted-Access Products

De Facto “Third Class”

  • The U.S. has an unofficial group of products that are nonprescription but have restricted/behind-the-counter access.

  • Other examples:

    • Dextromethorphan → may have state-specific age restrictions.

    • Some states give pharmacists prescriptive authority for specific drugs.


36
New cards

Pseudoephedrine

requirements

  • 3.6 g/day

  • 9 g/30 days

  • A logbook requirement exists.


37
New cards


38
New cards

Dietary supplements regulation?

Dietary supplements are regulated differently from OTC/Rx drugs, and FDA has less regulatory authority over them.

39
New cards

 Drug-Cosmetic Products

Drug-intended use + cosmetic-intended use

40
New cards

Drug-Cosmetic Products - example

Examples:

  • Anti-dandruff shampoo

  • Toothpaste


41
New cards

Drug-Cosmetic Products - Why important?

Different labeling requirements

🔴 KNOW

Standard Drug Facts inactive ingredients

→ generally alphabetical

Cosmetic ingredient lists

→ may be listed by weight

Therefore:

Do not assume the whole ingredient list is alphabetical.

Example:

Patient avoiding a dye → scan the entire ingredient list.

42
New cards

 Nonprescription Product Liability

  • OTC recommendation → stay within OTC labeling

  • Pharmacists may face malpractice/negligence when inaccurate advice harms a patient.


43
New cards

Nonprescription Product Liability = Potential liability:

  • Recommending OTC use outside the label.

  • Recommending a different therapy instead of prescribed therapy.

  • Failing to remove expired products.

  • Failing to remove recalled products.


44
New cards

Whiting v. Rite Aid

  • This case was used to reinforce that pharmacists should follow OTC label warnings and stay within labeled recommendations.


45
New cards

Follow OTC labeling →

safer recommendation + less liability risk.